ClinConnect ClinConnect Logo
Search / Trial NCT05632276

A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Performance and Safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive Dressings in the Management of Surgical and Traumatic Wounds

Launched by CONVATEC INC. · Nov 18, 2022

Trial Information

Current as of May 22, 2025

Completed

Keywords

ClinConnect Summary

A prospective, multi centre, interventional, non-comparator, open label study to demonstrate the efficacy, performance and safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive dressings in the management of surgical and traumatic wounds for up to 4 weeks

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 years and over
  • Patients able and willing to provide informed consent
  • Patients with Surgical wounds including incisional wounds including laparoscopic
  • wounds and surgical wounds healing by secondary intention.
  • Patients with Traumatic wounds
  • Patients must be willing to attend visits as per schedule in protocol
  • Exclusion criteria:
  • Patients with known allergies to any of the materials used in the dressing
  • Patients who require any oxidising agents such as hydrogen peroxide or hypochlorite solutions.
  • Patients, who in the opinion of the investigator, is considered unsuitable for any other reason
  • Patients with wounds showing signs of infection on presentation or not resolving with the use of antibiotics

About Convatec Inc.

ConvaTec Inc. is a global medical technology company dedicated to the development and commercialization of innovative products and solutions for the management of chronic and acute medical conditions. With a focus on advanced wound care, ostomy care, continence and critical care, and infusion devices, ConvaTec aims to enhance the quality of life for patients through evidence-based practices and cutting-edge research. The company is committed to clinical excellence and actively sponsors clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of healthcare delivery and patient outcomes.

Locations

Winston Salem, North Carolina, United States

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Kerem Ozer, MD

Study Chair

Medical Director

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials